Acrivon Therapeutics, Inc.

NasdaqGM:ACRV Stock Report

Market Cap: US$203.9m

Acrivon Therapeutics Balance Sheet Health

Financial Health criteria checks 6/6

Acrivon Therapeutics has a total shareholder equity of $196.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $214.7M and $17.8M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$187.45m
EquityUS$196.89m
Total liabilitiesUS$17.79m
Total assetsUS$214.68m

Recent financial health updates

Recent updates

We're Not Very Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate

Nov 17
We're Not Very Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate

Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects

Sep 18

Is Acrivon Therapeutics (NASDAQ:ACRV) In A Good Position To Invest In Growth?

Jul 17
Is Acrivon Therapeutics (NASDAQ:ACRV) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation

Mar 29
Here's Why We're Not Too Worried About Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation

Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Oct 05
Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

Jun 22
Acrivon Therapeutics (NASDAQ:ACRV) Is In A Good Position To Deliver On Growth Plans

We Think Acrivon Therapeutics (NASDAQ:ACRV) Can Afford To Drive Business Growth

Feb 22
We Think Acrivon Therapeutics (NASDAQ:ACRV) Can Afford To Drive Business Growth

Financial Position Analysis

Short Term Liabilities: ACRV's short term assets ($189.0M) exceed its short term liabilities ($14.8M).

Long Term Liabilities: ACRV's short term assets ($189.0M) exceed its long term liabilities ($3.0M).


Debt to Equity History and Analysis

Debt Level: ACRV is debt free.

Reducing Debt: ACRV had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ACRV has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: ACRV has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 46.2% each year.


Discover healthy companies